# Teeni.AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/teeni-ai

- Industry: Consumer Products
- Headquarters: Beijing, China
- Website: www.teeni.com/
- Latest round: Angel (Mar 25, 2025)
- Investors on record: 3

## About

Teeni.AI, based in Beijing, China, develops innovative auditory solutions aimed at enhancing hearing experiences for individuals with hearing impairments through advanced technology and user-centric design.Founded in 2021, Teeni.AI focuses on creating auditory solutions, primarily hearing aids, to improve sound clarity and speech recognition for those with hearing loss. Their headquarters is located in Beijing, China. The company has completed one significant deal as of March 25, 2025, involving funding from Sense Capital and other investors. The founder's background is currently not disclosed.Teeni.AI, through its brand ???, specializes in auditory solutions that enhance hearing experiences for individuals with hearing impairments. Its flagship product is a state-of-the-art hearing aid that incorporates advanced sound processing technologies, offering clearer sound quality and improved speech recognition. This product, released in 2021, targets individuals with hearing loss, healthcare providers, audiologists, and direct consumers, focusing on key markets in Asia, Europe, and North America.Teeni.AI's revenue model revolves around direct-to-consumer sales and partnerships with healthcare professionals. Transactions typically involve one-time payments for hearing aids and accessories or subscription services for ongoing support. The company provides various pricing plans to cater to different customer segments, ensuring affordability while upholding high standards of technology and customer service. The sales of their flagship hearing aid are pivotal to their revenue generation strategy, responding to the growing demand for effective hearing solutions.Teeni.AI plans to leverage its recent Angel funding, raised in March 2025, to support the development of new auditory products slated for release in late 2025. The company aims to expand its market presence in North America and Europe, specifically targeting health institutions and direct consumers, by the end of 2025. The funding will be used to enhance product development, marketing efforts, and operational capabilities to facilitate this expansion.

## Funding rounds

- Angel, Mar 25, 2025 — ZMC, Lanchi Ventures, Sense Capital

## Investors

- ZMC (https://capitalatlas.ai/funds/zmc) — Angel
- Lanchi Ventures (https://capitalatlas.ai/funds/lanchi-ventures) — Angel
- Sense Capital (https://capitalatlas.ai/funds/sense-capital) — Angel